HopeStage
Back to all studies
Not recruitingISRCTN69617477

Double-blind, placebo-controlled, randomised, clinical trial of eicosapentaenoic acid in the treatment of mood disorders among middle-aged women

Research studyCanadaDepression
The study in practice

Understand this study

Listed locations
Canada

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Foundation Lucie et André Chagnon (Canada)
Sponsor type
Non-profit organization
Study type
Other
Intervention type
Other / unclear
Locations
Canada
Age range
Not clearly listed
Official registry ID
ISRCTN69617477
Official title
Show the full official title

Double-blind, placebo-controlled, randomised, clinical trial of eicosapentaenoic acid in the treatment of mood disorders among middle-aged women

Recruitment & locations

Not recruiting

Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Foundation Lucie et André Chagnon (Canada).

Is this study still recruiting?

The registry lists this study as not recruiting.

Want to explore more studies?

Explore studies